Article By:
Benzinga
Sunday, October 4, 2020 4:24 PM EDT
Biotech stocks made a steady recovery over the week ended October 2, although Friday's weakness trimmed some of the gains of the week. Companies working on anti-COVID-19 antibody treatments were in the news during the week.
Exclusive Interview With Lindsay Rosenwald, CEO Of Fortress Biotech
Good article @[Lindsay A. Rosenwald](user:126299). Sounds like $FBIO is on the right track. But how might the growing threat of the coronavirus impact your company?
Exclusive Interview With Lindsay Rosenwald, CEO Of Fortress Biotech
I've liked $FBIO for a while now.
Exclusive Interview With Lindsay Rosenwald, CEO Of Fortress Biotech
$FBIO sounds like a pretty innovative company.